BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
BioLineRx Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026
$1.98−0.03 (-1.49%)
Close on Oct 19, 2026
- Market cap
- $5.28B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 31, 2026 | Before market open | $300.00K | $0.00 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 23, 2026 | Before market open | – | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 31, 2025 | Before market open | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 15, 2024 | Before market open | $5.40M | $0.00 | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 26, 2024 | Before market open | $4.80M | – | – |
| Q4 FY2022 Ended Dec 31, 2022 | Mar 22, 2023 | Before market open | – | – | – |
| Q4 FY2021 Ended Dec 31, 2021 | Mar 16, 2022 | Before market open | – | – | – |
Press releases
Announcements BioLineRx filed with the SEC
PRESS RELEASE, DATED SEPTEMBER 10, 2026
EX-99 to Form 6-K
EX-99#2 to Form 6-K
EX-99#2 to Form 6-K
You should read the following discussion of
EX-99#3 to Form 6-K
For the Annual General Meeting of Shareholders
EX-99.2 to Form 6-K
FORM OF VOTING INSTRUCTION FORM
EX-99.3 to Form 6-K
and Hemispherian Announce New Preclinical Data Demonstrating Strong
EX-99 to Form 6-K
REGISTRANT'S PRESS RELEASE DATED MAY 27, 2026;
EX-99 to Form 6-K
REGISTRANT'S PRESS RELEASE DATED NOVEMBER 24, 2025;
EX-99 to Form 6-K
EX-99 to Form 6-K
EX-99 to Form 6-K
REGISTRANT'S PRESS RELEASE DATED MAY 30, 2025
EX-99 to Form 6-K
REGISTRANT'S PRESS RELEASE DATED MAY 27, 2025;
EX-99 to Form 6-K
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
EX-99.1 to Form 6-K
For the Annual General Meeting of Shareholders
EX-99.2 to Form 6-K
BNY: PO BOX 505006, Louisville, KY 40233-5006
EX-99.3 to Form 6-K
BioLineRx Reports 2024 Financial Results and Provides Corporate Update
EX-99.1 to Form 6-K
BIOLINERX ISSUES LETTER TO SHAREHOLDERS
EX-99.1 to Form 6-K
REGISTRANT'S PRESS RELEASE DATED JANUARY 6, 2025.
EX-99.1 to Form 6-K
REGISTRANT'S PRESS RELEASE DATED NOVEMBER 25, 2024.
EX-99 to Form 6-K
PRESS RELEASE, DATED NOVEMBER 21, 2024
EX-99.1 to Form 6-K
REGISTRANT'S PRESS RELEASE DATED NOVEMBER 5, 2024
EX-99.1 to Form 6-K